Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MVR:GR

10.218 EUR 0.122 1.18%

As of 15:17:34 ET on 01/30/2015.

Snapshot for Medivir AB (MVR)

Open: 10.116 Day's Range: 10.115 - 10.218 Volume: 0
Previous Close: 10.340 52wk Range: 9.208 - 16.420 1-Yr Rtn: +1.87%

Stock Chart for MVR

No chart data available.
  • MVR:GR 10.149
  • 1D
  • 1M
  • 1Y
10.340
Interactive MVR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 2.4860
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 38.4020
Est. PEG Ratio -
Market Cap (M EUR) 328.42
Shares Outstanding (M) 30.60
30 Day Average Volume 151
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVR

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVR

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Niklas PragerPresident/CEOChristina KassbergExec VP:Finance & Administration
Paul WallaceExec VP:Business DevelopmentRein PiirExec VP:Corporate Affairs
More Company Profile & Key Executives for MVR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil